Skip to main content
ARTELO BIOSCIENCES, INC. logo

ARTELO BIOSCIENCES, INC. — Investor Relations & Filings

Ticker · ARTL ISIN · US04301G7060 US Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2015-01-23 Regulatory Filings
Country US United States of America
Listing US ARTL

About ARTELO BIOSCIENCES, INC.

https://artelobio.com/

Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapeutics. The company's scientific approach is centered on modifying lipid-signaling pathways, particularly by modulating the endocannabinoid system. Its primary therapeutic focus is on developing improved treatments for patients with cancer and other serious diseases. Artelo is advancing a diverse portfolio of drug candidates through its development pipeline to address unmet medical needs.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting effectiveness of a Registration Statement on Form S-1. It is not a financial report, earnings release, or any other type of report but rather a regulatory communication related to the registration process for securities. The document length is short (1646 characters) and it is a formal request letter, not a report or announcement of financial results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory communications that do not fit other specific categories.
2015-01-23 English
FORM S-1 AMENDMENT NO. 1
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement Amendment No. 2 filed with the SEC by Knight Knox Development Corp. It is a registration statement under the Securities Act of 1933 for an initial public offering (IPO) of common stock. The document includes detailed information about the offering, company background, risk factors, use of proceeds, financial statements, and management discussion. It is not an annual report, earnings release, or any other type of periodic financial report. Instead, it is a capital markets filing related to the company's initial public offering and registration of securities. According to the filing definitions, updates on company fundraising or capital structure changes fall under Capital/Financing Update (CAP). Since this is a registration statement for an IPO, it is best classified as a Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement text, not just an announcement or notice, so it is not RPA or RNS. Therefore, the correct classification is CAP with high confidence.
2015-01-23 English
FORM S-1 AMENDMENT NO. 1
Regulatory Filings Classification · 100% confidence The document is a Form S-1 Registration Statement Amendment No. 1 filed with the SEC by Knight Knox Development Corp. It is a registration statement under the Securities Act of 1933 for an initial public offering (IPO) of common stock. The document includes detailed information about the offering, company background, risk factors, use of proceeds, financial statements, and management discussion. It is not an annual report, earnings release, or any other type of periodic financial report. Instead, it is a regulatory filing specifically for registering securities for sale to the public. Form S-1 filings are typically classified as Regulatory Filings (RNS) in the context of financial document classification because they are SEC registration statements and do not fit into other categories like Annual Report or Earnings Release. The document length is substantial (15,000 characters), and it contains the full registration statement text, not just an announcement or a certification. Therefore, the appropriate classification is Regulatory Filings (RNS).
2014-12-24 English
Regulatory Filings 2014
Regulatory Filings
2014-11-03 English
FORM S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used by companies to register securities for an initial public offering (IPO). It includes detailed information about the company, the offering, risk factors, use of proceeds, financial statements, and management discussion. The presence of the term 'Prospectus' and the detailed offering information confirms this is a registration statement for a securities offering, not a financial report like an Annual Report or Earnings Release. The document is lengthy (15,000 characters) and contains substantive content, not just an announcement or certification. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities such as IPO registration statements.
2014-10-08 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.